Nectar Laboratories Private Limited

Composition	LULICONAZOLE 1%
Packaging Size	15GMGS
Brand	LULIRATE CREAM 15GMS
Form Type	CREAM
Usage/Application	EXTERNAL
Benefits	Patients diagnosed with tinea corporis/tinea cruris were assigned to group 1 or 2 to receive 1% luli
Caution	NA
Dosage Form	TWICE DAILY
Drug Name	LULICONAZOLE 1%
Country of Origin	Made in India

Patients diagnosed with tinea corporis/tinea cruris were assigned to group 1 or 2 to receive 1% luliconazole(LULIRATE 15GMS) cream OD for 2 weeks or 1% clotrimazole BD for 4 weeks. Skin scrapings were taken for mycological assessment. Clinical assessment, KOH mount and culture was done at each visit. Clinical and mycological cure were assessed at each visit. Efficacy parameters were analyzed using Mann Whitney U test and Wilcoxon signed rank rest. RESULTS : Totally 158 patients were screened, 104 were randomized , 4 withdrew consent after randomization , hence each group had 50 patients. At the end of first week, luliconazole 1% group showed significant improvement in clinical cure and mycological cure ( p<0.05) than 1% clotrimazole group. Mycological cure was high in luliconazole group(p<0.05). Relapse was high in clotrimazole group( p <0.05). CONCLUSION : Topical luliconazole was better in achieving faster mycological and clinical cure with lower relapse.

Additional Information:

• Item Code: LRTE
• Production Capacity: 5000
• Delivery Time: 24HRS
• Packaging Details: 1*15GMS*50

Composition	LULICONAZOLE 1%
Packaging Size	30GMS
Brand	LULIRATE 30GMS
Form Type	CREAM
Usage/Application	EXTERNAL
Benefits	COMPREHENSIVE THERAPY
Caution	NA
Dosage Form	CREAM
Country of Origin	Made in India

Patients diagnosed with tinea corporis/tinea cruris were assigned to group 1 or 2 to receive 1% luliconazole cream (LULIRATE 30GMS)OD for 2 weeks or 1% clotrimazole BD for 4 weeks. Skin scrapings were taken for mycological assessment. Clinical assessment, KOH mount and culture was done at each visit. Clinical and mycological cure were assessed at each visit. Efficacy parameters were analyzed using Mann Whitney U test and Wilcoxon signed rank rest. RESULTS : Totally 158 patients were screened, 104 were randomized , 4 withdrew consent after randomization , hence each group had 50 patients. At the end of first week, luliconazole 1% group showed significant improvement in clinical cure and mycological cure ( p<0.05) than 1% clotrimazole group. Mycological cure was high in luliconazole group(p<0.05). Relapse was high in clotrimazole group( p <0.05). CONCLUSION : Topical luliconazole was better in achieving faster mycological and clinical cure with lower relapse.

Additional Information:

• Item Code: LLRT
• Production Capacity: 100000
• Delivery Time: 24HRS
• Packaging Details: 330GSM